The study found financial associations for 95 of 170 DSM panel members, or 56%. Every member of the Mood Disorders and Schizophrenia and Other Psychotic Disorders panels had financial ties.
Of the 170 DSM panel members 95 (56%) had one or more financial associations with companies in the pharmaceutical industry.
The study found financial associations for 95 of 170 DSM panel members, or 56%. Every member of the Mood Disorders and Schizophrenia and Other Psychotic Disorders panels had financial ties. Documents associations, not proof that industry caused particular diagnostic criteria.